Yahoo Finance: Beacon Capital's Investments Validated by the Passing of the 'Right-To-Try' Bill

Beacon Capital, a venture and philanthropy arm of Beacon Pharmaceutical, is building a "Right-To-Try" platform. Right-To-Try legislation allows terminally ill patients access to investigational therapies – including medical devices, and biologics – that have passed basic safety and dosage testing (Phase I) with the FDA, but are not yet available to the broader public. READ ARTICLE


19 views
LINKS
ABOUT

2000 PGA Boulevard #4440, Palm Beach Gardens, FL 33408

info@beaconpharmaceutical.com

Tel: 212-991-8988

SOCIAL
  • Facebook
  • YouTube
  • Twitter
  • Instagram
telegram logo.png

© 2019 BEACON PHARMACEUTICAL JUPITER

Beacon Pharmaceutical